| 引用本文：庞慧敏,王小万.欧盟形成医药单一市场的挑战与趋势[J].中国卫生政策研究,2009,2(3):42-46 |
|
| 欧盟形成医药单一市场的挑战与趋势 |
| 投稿时间：2009-02-11 修订日期：2009-02-17 PDF全文浏览 HTML全文浏览 |
| 庞慧敏1, 王小万2 |
| 1.北京协和医学院医学信息研究所;2.中国医学科学院卫生政策与管理研究中心 |
| 摘要:本文通过综述欧盟医药卫生政策，阐述了欧盟相关的平衡医疗保障政策、医药产业政策和公共卫生政策的重要性，欧盟与成员国、成员国内等因素对欧盟医药政策的影响，以及政府与医药企业之间的关系，系统分析了欧洲医药单一市场迟迟没有形成的原因。由于欧盟与成员国、政府与医药企业之间存在强大利益冲突，欧盟目前仍无法形成医药单一市场。 |
| 关键词:欧盟 医药单一市场 医药政策 |
|
| The challenges and trends of the formation of a single European pharmaceutical market |
| PANG Hui-min1, WANG Xiao-wan2 |
| 1.Institute of Medical Information, Peking Union Medical College;2.Center for Health Policy and Management, Chinese Academy of Medical Sciences |
| Abstract:This paper summarized the policies of pharmaceuticals in European Union, elaborated the importance of balancing the health care policy, industrial policy and public health policy; Analyzed the reason of still lacking a single European pharmaceuticals market, how the national supranational interests and competencies, Government industry relations influence the politics of pharmaceuticals. In conclusion the conflict of interests between EU and Member states, government and industry hampered the foundation of a single pharmaceutical market in the European Union. |
| Key words:European Union, A single European pharmaceuticals market, Pharmaceutical policy |
| 摘要点击次数: 3469 全文下载次数: 5501 |
|
|
